Key players in Pharmacogenomic Testing for Psychiatry
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Myriad Genetics, Inc. |
myriad.com (opens in a new tab) | 297 reports |
| 2 | Genomind | — | 66 reports |
| 3 | OneOme | — | 66 reports |
| 4 | Tempus | — | 132 reports |
| 5 | Thermo Fisher Scientific Inc. | — | 1,023 reports |
Pharmacogenomic Testing for Psychiatry reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Pharmacogenomic Testing for Psychiatry report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.